- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/68 - Stabilisation of the vector
Patent holdings for IPC class C12N 15/68
Total number of patents in this class: 152
10-year publication summary
12
|
8
|
8
|
17
|
11
|
6
|
10
|
11
|
11
|
4
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Curevac SE | 259 |
11 |
BioNTech SE | 619 |
9 |
Curevac GmbH | 52 |
4 |
International AIDS Vaccine Initiative | 89 |
4 |
Tron - Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg- Universitat Mainz gGmbH | 57 |
4 |
BlueAllele, LLC | 18 |
4 |
Massachusetts Institute of Technology | 9942 |
3 |
Case Western Reserve University | 1782 |
3 |
CureVac AG | 137 |
3 |
King Faisal Specialist Hospital and Research Centre | 10 |
3 |
National University of Singapore | 2399 |
3 |
BASF SE | 20616 |
2 |
BioNTech AG | 80 |
2 |
BioNTech RNA Pharmaceuticals GmbH | 74 |
2 |
Ethris GmbH | 101 |
2 |
Fuso Pharmaceutical Industries, Ltd. | 123 |
2 |
National University Corporation Hokkaido University | 1330 |
2 |
TERRAMARK MARKENCREATION GmbH | 76 |
2 |
Tron-translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-universitat Mainz Gemeinnutzige GmbH | 165 |
2 |
Universitat Autonoma de Barcelona | 314 |
2 |
Other owners | 83 |